Somatostatin treatment of congenital chylothorax may induce transient hypothyroidism in newborns

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 6, 2005, Pages 785-789

  Maayan Metzger, Ayala ^a,b   Sack, Joseph ^a   Mazkereth, Ram ^a   Vardi, Amir ^a   Kuint, Jacob ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Chylothorax; Hypothyroidism; Somatostatin

Indexed keywords

LEVOTHYROXINE; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ARTICLE; CHRONIC LUNG DISEASE; CHYLE; CHYLOTHORAX; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL DISORDER; CONGENITAL MALFORMATION; DISEASE SEVERITY; FETUS HYDROPS; FETUS SURGERY; GRAM NEGATIVE SEPSIS; HOSPITALIZATION; HUMAN; HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; LENGTH OF STAY; MEDICAL RECORD; NEWBORN; PATIENT MONITORING; PREMATURITY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST; THROMBOCYTOPENIA; THYROID FUNCTION; TREATMENT FAILURE;

CHYLOTHORAX; HUMANS; HYPOTHYROIDISM; INFANT; INFANT, NEWBORN; SOMATOSTATIN;

EID: 20544467966     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035250510027598     Document Type: Article

References (17)

1. Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C. Etiology and management of chylothorax. J Pediatr 2000;136:653-8.
2. Chinnock BF. Chylothorax: Case report and review of the literature. J Emerg Med 2003;24:259-62.
3. Machleder HI, Paulus H. Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage. Surgery 1978;84:157-65.
4. Ulibarri JI, Sanz Y, Fuentes C, Mancha A, Armendia M, Sanchez S. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatine. Lancet 1990;336:258.
5. Buettiker V, Hug MI, Burger R, Baenziger O. Somatostatine: a new therapeutic option for the treatment of chylothorax. Intensive Care Med 2001;27:1083-6.
6. Cheung Y, Leung MP, Yip M. Octreotide for treatment of postoperative chylothorax. J Pediatr 2001;139:157-9.
7. Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut 1994;35 Suppl 3:S1-4.
8. Cone RD, Low MJ, Elmquist JK, Cameron JL. Clinical application of somatostatin analogues. In: Reed Larsen P, Kronenberg HM, Melmed S, Polonsky KS, editors. Williams textbook of endocrinology. 10th ed. Philadelphia, Pennsylvania, USA: Saunders; 1996. p. 124.
9. Lamberts SW, Oosterom R, Neufeld M, del Pozo E. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients. J Clin Endocrinol Metab 1985;60:1161-5.
10. Nakabayashi H, Sagara H, Usukura N, Yoshimitsu K, Imamura T, Seta T, et al. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs. Diabetes 1981;30:440-5.
11. Al-Tawil K, Ahmed G, Al-Hathal M, Al-Jarallah Y, Campbell N. Congenital chylothorax. Am J Perinatol 2000;17:121-6.
12. Itoh S, Tanaka K, Kumagae M, Takeda F, Morio K, Kogure M, et al. Effect of subcutaneous injection of a long-acting analogue of somatostatin (SMS 201-995) on plasma thyroid-stimulating hormone in normal human subjects. Life Sci 1988;42:2691-9.
13. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD. Thyrotropin-secreting pituitary tumors. Endocr Rev 1996;17:610-38.
14. Linder N, Sela B, German B, Davidovitch N, Kuint J, Hegesh J, et al. Iodine and hypothyroidism in neonates with congenital heart disease. Arch Dis Child Fetal Neonatal Ed 1997;77: F239-40.
15. Sack J, Kaiserman I, Eidlitz-Markus T. The importance of thyroglobulin levels in monitoring the treatment of congenital hypothyroidism. Horm Res 1995;44:23-8.
16. Fisher DA, Schoen EJ, La Franchi S, Mandel SH, Nelson JC, Carlton EI, et al. The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism. J Clin Endocrinol Metab 2000;85: 2722-7.
17. Reed Larsen P, Davies TF, Schlumberger MJ, Hay ID. Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Reed Larsen P, Kronenberg HM, Melmed S, Polonsky KS, editors. Williams textbook of endocrinology. 10th ed. Philadelphia, Pennsylvania, USA: Saunders; 1996. p. 351.